Efficacy and safety of once daily oral administration of sodium-glucose cotransporter-2 inhibitor velagliflozin compared with twice daily insulin injection in diabetic cats.
Stijn J M NiessenHans S KooistraYaiza ForcadaCharlotte Reinhard BjørnvadBalazs AlbrechtFranziska RoessnerEsther HerberichCarla KrohPublished in: Journal of veterinary internal medicine (2024)
Once daily oral administration of velagliflozin was noninferior to insulin injections, showed good QoL and glycemia without clinical hypoglycemia.